Cohance Lifesciences Limited
COHANCE
Classificação em ações
#6340
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Preço da ação
$5.09
Valor de mercado
$1.95B
Variação (1 dia)
0.69%
Variação (1 ano)
-57.08%
País
IN
Negociar Cohance Lifesciences Limited (COHANCE)
Categoria
Healthcare
Rácio P/B de Cohance Lifesciences Limited (COHANCE)
Rácio P/B em October 2026 TTM: 22.54
De acordo com os relatórios financeiros mais recentes e o preço das ações da Cohance Lifesciences Limited, o rácio P/B atual (TTM) é 22.54. No final de 2024, o rácio P/B era 8.31.
Histórico do rácio P/B da Cohance Lifesciences Limited de 2019 a 2026
Rácio P/B no final de cada ano
| Ano | Rácio P/B | Alterar |
|---|---|---|
| 2026 (TTM) | 22.54 | 41.50% |
| 2025 | 15.93 | 91.72% |
| 2024 | 8.31 | 19.91% |
| 2023 | 6.93 | -32.77% |
| 2022 | 10.31 | -3.75% |
| 2021 | 10.71 | 253.56% |
| 2020 | 3.03 | -58.32% |
| 2019 | 7.27 | 0.00% |
Rácio P/B de empresas semelhantes ou concorrentes
| Empresa | Rácio P/B | Diferença do rácio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -77.64% |
IN
|
